619 related articles for article (PubMed ID: 18066090)
1. DNA damage signalling guards against activated oncogenes and tumour progression.
Bartek J; Bartkova J; Lukas J
Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Bartkova J; Horejsí Z; Koed K; Krämer A; Tort F; Zieger K; Guldberg P; Sehested M; Nesland JM; Lukas C; Ørntoft T; Lukas J; Bartek J
Nature; 2005 Apr; 434(7035):864-70. PubMed ID: 15829956
[TBL] [Abstract][Full Text] [Related]
3. Human cell senescence as a DNA damage response.
von Zglinicki T; Saretzki G; Ladhoff J; d'Adda di Fagagna F; Jackson SP
Mech Ageing Dev; 2005 Jan; 126(1):111-7. PubMed ID: 15610769
[TBL] [Abstract][Full Text] [Related]
4. DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy.
Bartkova J; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
Int J Androl; 2007 Aug; 30(4):282-91; discussion 291. PubMed ID: 17573848
[TBL] [Abstract][Full Text] [Related]
5. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.
Larsson LG
Semin Cancer Biol; 2011 Dec; 21(6):367-76. PubMed ID: 22037160
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis.
Tort F; Bartkova J; Sehested M; Orntoft T; Lukas J; Bartek J
Cancer Res; 2006 Nov; 66(21):10258-63. PubMed ID: 17079443
[TBL] [Abstract][Full Text] [Related]
7. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
Di Micco R; Fumagalli M; Cicalese A; Piccinin S; Gasparini P; Luise C; Schurra C; Garre' M; Nuciforo PG; Bensimon A; Maestro R; Pelicci PG; d'Adda di Fagagna F
Nature; 2006 Nov; 444(7119):638-42. PubMed ID: 17136094
[TBL] [Abstract][Full Text] [Related]
8. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
Bartek J; Lukas J; Bartkova J
Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
[TBL] [Abstract][Full Text] [Related]
9. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou LV; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
Nature; 2006 Nov; 444(7119):633-7. PubMed ID: 17136093
[TBL] [Abstract][Full Text] [Related]
10. Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression.
Nuciforo PG; Luise C; Capra M; Pelosi G; d'Adda di Fagagna F
Carcinogenesis; 2007 Oct; 28(10):2082-8. PubMed ID: 17522062
[TBL] [Abstract][Full Text] [Related]
11. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
12. Oxidation in the nucleotide pool, the DNA damage response and cellular senescence: Defective bricks build a defective house.
Rai P
Mutat Res; 2010 Nov; 703(1):71-81. PubMed ID: 20673809
[TBL] [Abstract][Full Text] [Related]
13. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
[TBL] [Abstract][Full Text] [Related]
14. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
Felsher DW
Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
[TBL] [Abstract][Full Text] [Related]
15. Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.
Bartek J; Fornara O; Merchut-Maya JM; Maya-Mendoza A; Rahbar A; Stragliotto G; Broholm H; Svensson M; Sehested A; Söderberg Naucler C; Bartek J; Bartkova J
Mol Oncol; 2017 Aug; 11(8):945-964. PubMed ID: 28383788
[TBL] [Abstract][Full Text] [Related]
16. Senescence as an anticancer mechanism.
Hornsby PJ
J Clin Oncol; 2007 May; 25(14):1852-7. PubMed ID: 17488983
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in research on multistage tumorigenesis.
Compagni A; Christofori G
Br J Cancer; 2000 Jul; 83(1):1-5. PubMed ID: 10883659
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence: hot or what?
Evan GI; d'Adda di Fagagna F
Curr Opin Genet Dev; 2009 Feb; 19(1):25-31. PubMed ID: 19181515
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of oxidative DNA damage during senescence: the first step toward carcinogenesis?
Martien S; Abbadie C
Ann N Y Acad Sci; 2007 Nov; 1119():51-63. PubMed ID: 18056954
[TBL] [Abstract][Full Text] [Related]
20. The impact of DNA damage, genetic mutation and cellular responses on cancer prevention, longevity and aging: observations in humans and mice.
Hasty P
Mech Ageing Dev; 2005 Jan; 126(1):71-7. PubMed ID: 15610764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
